Measuring antiplatelet drug effects in the laboratory |
| |
Authors: | Harrison Paul Frelinger A L Furman Mark I Michelson Alan D |
| |
Institution: | Oxford Haemophilia Centre and Thrombosis Unit, Churchill Hospital, Oxford, United Kingdom. |
| |
Abstract: | This review discusses the advantages and disadvantages of currently available tests for the monitoring of antiplatelet therapy (especially aspirin and clopidogrel). Many tests of platelet function are now available for clinical use, and some of these tests have been shown to predict clinical outcomes after antiplatelet therapy. However, in most of these studies, the number of major adverse clinical events was low. No published studies address the clinical effectiveness of altering therapy based on the results of monitoring antiplatelet therapy. Therefore, the correct treatment, if any, of "resistance" to antiplatelet therapy is unknown and, other than in research trials, monitoring of antiplatelet therapy in patients is not generally recommended. A clinically meaningful definition of "resistance" to antiplatelet drugs needs to be developed, based on data linking drug-dependent laboratory tests to clinical outcomes in patients. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|